Hong Fang Song sold $20M of CGON
director at CG Oncology, Inc.. 700,000 shares at an average of $28.00, traded Dec 16, 2024, filed Dec 17, 2024.
Score components
- +15RoleDirector
- +25Trade size$19.6M at market
- +5Share of holdings soldSold 19% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.6%, 3m -6.1%, 6m -10.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-029664, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Charming Jade Limited | -700,000 | $28.00 | $20M | 3,003,931 | Dec 17, 2024 |
Related signals
Other insiders at CG Oncology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | CG Oncology, Inc. | Leonard E Post director | $73k 1,000 shares | -100% | |
| 10Weak | CG Oncology, Inc. | James Mulay director | $125k 1,964 shares | -300% | |
| 19Weak | CG Oncology, Inc. | James Mulay director | $585k 11,145 shares | -1704% | |
| 6Weak | CG Oncology, Inc. | Leonard E Post director | $41k 1,000 shares | -100% | |
| 14Weak | CG Oncology, Inc. | Leonard E Post director | $43k 1,000 shares | -100% | |
| 21Weak | CG Oncology, Inc. | James Mulay director | $260k 5,903 shares | -100% | |
| 20Weak | CG Oncology, Inc. | Leonard E Post director | $200k 5,000 shares | -100% | |
| 26Weak | CG Oncology, Inc. | James Mulay director | $500k 12,755 shares | -100% | |
| 31Weak | CG Oncology, Inc. | James Mulay director | $885k 22,686 shares | -119% | |
| 21Weak | CG Oncology, Inc. | Leonard E Post director | $35k 1,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.